Latest filing published 11 Sept 2026 for Shanghai Henlius Biotech, Inc. - H Shares, €4,078.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Chan Lik Yuen: trading record in brief
All filings by Chan Lik Yuen on record concern Shanghai Henlius Biotech, Inc. - H Shares. Over a trading history stretching from 29 August 2026 to 8 September 2026, the count stands at 2 filings.
On the market, this insider has only sold: 1 sale, €4,078 in total.
The newest entry dates from 11 September 2026: an open-market sale of €4,078, in Shanghai Henlius Biotech, Inc. - H Shares. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Companies and markets linked to Chan Lik Yuen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 540 shares@ HK$68.8982ShareXHKGHKEX:DA20260911E00465
- 1,650 sharesShareXHKGHKEX:DA20260902E00395
2 of 2 declarations